Post-translational glycosylation of coronavirus glycoprotein E1: inhibition by monensin
- PMID: 6327272
- PMCID: PMC553242
- DOI: 10.1002/j.1460-2075.1982.tb01346.x
Post-translational glycosylation of coronavirus glycoprotein E1: inhibition by monensin
Abstract
The intracellular sites of biosynthesis of the structural proteins of murine hepatitis virus A59 have been analyzed using cell fractionation techniques. The nucleocapsid protein N is synthesized on free polysomes, whereas the envelope glycoproteins E1 and E2 are translated on the rough endoplasmic reticulum (RER). Glycoprotein E2 present in the RER contains N-glycosidically linked oligosaccharides of the mannose-rich type, supporting the concept that glycosylation of this protein is initiated at the co-translational level. In contrast, O-glycosylation of E1 occurs after transfer of the protein to smooth intracellular membranes. Monensin does not interfere with virus budding from the membranes of the endoplasmic reticulum, but it inhibits virus release and fusion of infected cells. The oligosaccharide side chains of E2 obtained under these conditions are resistant to endoglycosidase H and lack fucose suggesting that transport of this glycoprotein is inhibited between the trans Golgi cisternae and the cell surface. Glycoprotein E1 synthesized in the presence of monensin is completely carbohydrate-free. This observation suggests that the intracellular transport of this glycoprotein is also blocked by monensin.
Similar articles
-
Infection of AtT20 murine pituitary tumour cells by mouse hepatitis virus strain A59: virus budding is restricted to the Golgi region.Eur J Cell Biol. 1985 May;37:203-12. Eur J Cell Biol. 1985. PMID: 2992976
-
Replication of coronavirus MHV-A59 in sac- cells: determination of the first site of budding of progeny virions.Eur J Cell Biol. 1984 Mar;33(2):281-93. Eur J Cell Biol. 1984. PMID: 6325194
-
Brefeldin A and monensin arrest cell surface expression of membrane glycoproteins and release of rubella virus.J Gen Virol. 1995 Apr;76 ( Pt 4):855-63. doi: 10.1099/0022-1317-76-4-855. J Gen Virol. 1995. PMID: 9049331
-
Laminated cisternae of the rough endoplasmic reticulum induced by coronavirus MHV-A59 infection.Eur J Cell Biol. 1985 Jan;36(1):108-15. Eur J Cell Biol. 1985. PMID: 2983995
-
HCV E2 glycoprotein: mutagenesis of N-linked glycosylation sites and its effects on E2 expression and processing.Virology. 2004 Feb 5;319(1):36-48. doi: 10.1016/j.virol.2003.10.008. Virology. 2004. PMID: 14967486
Cited by
-
Repurposing Polyether Ionophores as a New-Class of Anti-SARS-Cov-2 Agents as Adjunct Therapy.Curr Microbiol. 2023 Jul 6;80(8):273. doi: 10.1007/s00284-023-03366-1. Curr Microbiol. 2023. PMID: 37414909 Review.
-
Determination of binding affinity of tunicamycin with SARS-CoV-2 proteins: Proteinase, protease, nsp2, nsp9, ORF3a, ORF7a, ORF8, ORF9b, envelope and RBD of spike glycoprotein.Vacunas. 2023 Jan-Mar;24(1):1-12. doi: 10.1016/j.vacun.2022.10.006. Epub 2022 Nov 4. Vacunas. 2023. PMID: 36349218 Free PMC article.
-
Exploring the Potential of Chemical Inhibitors for Targeting Post-translational Glycosylation of Coronavirus (SARS-CoV-2).ACS Omega. 2022 Jul 28;7(31):27038-27051. doi: 10.1021/acsomega.2c02345. eCollection 2022 Aug 9. ACS Omega. 2022. PMID: 35937682 Free PMC article. Review.
-
Inhibition of N-linked Glycosylation by Tunicamycin May Contribute to The Treatment of SARS-CoV-2.Microb Pathog. 2020 Dec;149:104586. doi: 10.1016/j.micpath.2020.104586. Epub 2020 Oct 20. Microb Pathog. 2020. PMID: 33091582 Free PMC article. Review.
-
Screening for natural and derived bio-active compounds in preclinical and clinical studies: One of the frontlines of fighting the coronaviruses pandemic.Phytomedicine. 2021 May;85:153311. doi: 10.1016/j.phymed.2020.153311. Epub 2020 Aug 29. Phytomedicine. 2021. PMID: 33067112 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources